Effect of mangiferin isolated from Salacia chinensis regulates the kidney carbohydrate metabolism in streptozotocin–induced diabetic rats

ObjectiveThe present investigation was to evaluate the possible anti-diabetic effect of mangiferin from Salacia chinensis (S. chinensis) on the activities of kidney carbohydrate metabolic enzymes in chemically induced diabetic rats.MethodsDiabetes was induced by streptozotocin (STZ) in adult male rats, as a single intraperitoneal injection at a dose of 55 mg/kg body weight. The STZ-induced diabetic rats were treated by mangiferin and glibenclamide (positive control drug) for 30 days. At the end of the experiment, the rats were sacrificed and carbohydrate metabolic enzyme activities were analyzed in the kidney.ResultsDiabetic control rats showed a significant increase in the level of fasting blood glucose and also increase the activities of carbohydrate metabolic enzymes in kidney on successive days of the experiment as compared with their basal values. Daily oral administration of mangiferin showed a significant decrease in the blood glucose when compared to diabetic control. The anti-hyperglycemic effect was obtained with the dose of 40 mg/kg b.wt. In addition, treatment of mangiferin shows alteration in kidney carbohydrate metabolic enzymes including gluconeogenic enzymes like glucose-6-phosphatase and fructose-1,6-disphosphatase. These results were comparable with positive control drug, glibenclamide.ConclusionsThe results obtained in this study provide evidence of the anti-diabetic potential of mangiferin, mediated through the regulation of carbohydrate key metabolic enzyme activities.